| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/24/2011 | EP2358366A1 Pharmacokinetically-based dosing regimens of a thrombin receptor antagonist |
| 08/24/2011 | EP1951687B1 N-hydroxyamide derivatives and use thereof |
| 08/24/2011 | EP1912949B1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 08/24/2011 | EP1571155B1 Peptides and medicinal compositions containing the same |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/24/2011 | EP0692984B2 Systemic effects of nitric oxide inhalation |
| 08/24/2011 | CN1814165B Pulse-promoting slow-release capsule and preparing method |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 08/24/2011 | CN102164918A Solid pharmaceutical composition |
| 08/24/2011 | CN102164904A 6-substituted isoflavonoid compounds and uses thereof |
| 08/24/2011 | CN102164894A Heteroaryl antagonists of prostaglandin D2 receptors |
| 08/24/2011 | CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 08/24/2011 | CN102161963A Grass root wine and preparation method thereof |
| 08/24/2011 | CN102161656A Caspase inhibitors and uses thereof |
| 08/24/2011 | CN102161648A Preparation method and applications of isoflavone type compounds with selective estrogen receptor modulating activity |
| 08/24/2011 | CN102161644A Ligands for g-protein coupled receptors |
| 08/24/2011 | CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof |
| 08/24/2011 | CN102161627A Omega-(N-substituted-aminoalkyl)octanamide |
| 08/24/2011 | CN102160885A Chinese medicament for treating hypertension |
| 08/24/2011 | CN102160884A Chinese medicinal preparation for treating acute period vital myocarditis |
| 08/24/2011 | CN102160878A Chinese medicinal ointment preparation for treating hemorrhoids |
| 08/24/2011 | CN102160876A Plant extract composition for preventing and treating arteriosclerosis and preparation method thereof |
| 08/24/2011 | CN102160872A Compound salvia dropping pill capsules |
| 08/24/2011 | CN102160866A Application of tanshinone IIA or pharmaceutically acceptable salts thereof in preparing medicines for treating or preventing pulmonary hypertension disease |
| 08/24/2011 | CN102160853A Vinpocetine injection and preparation method thereof |
| 08/24/2011 | CN102160731A Health care pillow prepared from traditional Chinese medicine and preparation method and applications thereof |
| 08/24/2011 | CN101897753B Traditional Chinese medicine for treating coronary disease and preparation method thereof |
| 08/24/2011 | CN101869660B Capsules for treating chronic fatigue syndrome and climacteric syndrome |
| 08/24/2011 | CN101829190B Dandeng Tongnao tablets and preparation process thereof |
| 08/24/2011 | CN101732593B Compound antihypertensive tea |
| 08/24/2011 | CN101693046B Chinese medicine composition capable of improving anoxia endurance |
| 08/24/2011 | CN101612196B Chinese medicinal composition for preventing and curing heart cerebrovascular diseases and use thereof |
| 08/24/2011 | CN101579492B Medicine for treating high blood pressure and preparation method thereof |
| 08/24/2011 | CN101579361B Complex probiotics for curing hypertension and coronary heart disease and preparation method thereof |
| 08/24/2011 | CN101410385B Benzothiazoles having histamine H3 receptor activity |
| 08/24/2011 | CN101406630B Medicament for treating coronary heart disease |
| 08/24/2011 | CN101371917B Brain protein hydrolysate sodium chloride injection |
| 08/24/2011 | CN101327246B Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint |
| 08/24/2011 | CN101138633B BCG vaccine for preventing and reversing hypertrophy and fibrosis of cardiovascular organization |
| 08/24/2011 | CN100998648B Method for preparing compound red-rooted salvia enteric tablet |
| 08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
| 08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 08/23/2011 | US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 08/23/2011 | US8003648 Heterocyclic GPR40 modulators |
| 08/23/2011 | US8003643 Inhibitors of Akt activity |
| 08/23/2011 | US8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
| 08/23/2011 | CA2570763C Composition for preventing onset of cardiovascular events |
| 08/23/2011 | CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2465517C Drug eluting radially expandable tubular stented grafts |
| 08/23/2011 | CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/22/2011 | CA2693927A1 Use of celivarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization |
| 08/18/2011 | WO2011100659A2 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs |
| 08/18/2011 | WO2011100453A2 Compositions and methods for the treatment of cardiac and vascular disease |
| 08/18/2011 | WO2011100286A2 Compositions and methods of generating a differentiated mesodermal cell |
| 08/18/2011 | WO2011099882A1 Vaccine compositions and methods of use thereof |
| 08/18/2011 | WO2011099881A1 Pharmaceutical compositions containing antibodies to neuropeptide head activator and methods thereof |
| 08/18/2011 | WO2011099576A1 Aptamer to fgf2 and use thereof |
| 08/18/2011 | WO2011099570A1 Age production inhibitor |
| 08/18/2011 | WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
| 08/18/2011 | WO2011098776A1 5-ht receptor modulators |
| 08/18/2011 | WO2011098582A2 Novel forms of ivabradine hydrochloride |
| 08/18/2011 | WO2011097857A1 Antihypertensive pharmaceutical composition |
| 08/18/2011 | WO2011077163A3 Use |
| 08/18/2011 | WO2011060789A3 Treatment of acute ischemic stroke or intracranial bleeding with tpa and carbamylated erythropoietin |
| 08/18/2011 | WO2011056416A3 Cardiomyocyte production |
| 08/18/2011 | WO2011047345A3 Methods of treating diseases of conditions using mesenchymal stem cells |
| 08/18/2011 | WO2011047309A9 Treatment of ischemic tissue |
| 08/18/2011 | US20110202033 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 08/18/2011 | US20110201688 N,n'-di-p-bromophenyl guanidine treatment for stroke at delayed timepoints |
| 08/18/2011 | US20110201680 formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 08/18/2011 | US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/18/2011 | US20110201674 Saporin-L1 inhibitors and uses thereof |
| 08/18/2011 | US20110201673 Lpl variant therapeutics |
| 08/18/2011 | US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/18/2011 | US20110201658 Pharmaceutical package |
| 08/18/2011 | US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors |
| 08/18/2011 | US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/18/2011 | US20110201654 Therapeutic combination |
| 08/18/2011 | US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 08/18/2011 | US20110201640 Tricyclic compound |
| 08/18/2011 | US20110201634 Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same |
| 08/18/2011 | US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase |
| 08/18/2011 | US20110201621 Angiotensin ii receptor antagonists |
| 08/18/2011 | US20110201615 Triazole beta carboline derivatives as anti-diabetic agents |
| 08/18/2011 | US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
| 08/18/2011 | US20110201602 Protein kinase modulators and method of use |
| 08/18/2011 | US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |